An investigation for investors in NASDAQ:NYMX shares over potential securities laws violations by Nymox Pharmaceutical Corporation and certain of its directors and officers was announced.
Investors who purchased shares of Nymox Pharmaceutical Corporation (NASDAQ:NYMX), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – 1554.
The investigation by a law firm focuses on whether a series of statements by Nymox Pharmaceutical regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
On August 10, 2016, an article was published alleging that Nymox Pharmaceutical Corporation management has consistently and repeatedly misled shareholders about its prospects in a material way while dumping stock at inflated prices without making timely disclosures to the Securities and Exchange Commission. Shares of Nymox Pharmaceutical Corporation (NASDAQ:NYMX) declined from $4.02 per share on July 25, 2016 to as low as $1.62 per share on August 10, 2016.
Those who purchased NASDAQ:NYMX shares have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North – Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com